Approval · Notice of Compliance 2841 · 2003
REPRONEX: Notice of Compliance 2841
Issued July 2, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2841
- Date
- July 2, 2003
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Gonadotropins for infertility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REPRONEX | 02247790 | Cancelled Post Market |
Medicinal ingredients
- MENOTROPINS 75 UNIT per VIAL